Regulation of Human Breast Cancer by the Long Non-Coding RNA H19
AbstractBreast cancer is one of the most common causes of cancer related deaths in women. Despite the progress in early detection and use of new therapeutic targets associated with development of novel therapeutic options, breast cancer remains a major problem in public health. Indeed, even if the survival rate has improved for breast cancer patients, the number of recurrences within five years and the five-year relative survival rate in patients with metastasis remain dramatic. Thus, the discovery of new molecular actors involved in breast progression is essential to improve the management of this disease. Numerous data indicate that long non-coding RNA are implicated in breast cancer development. The oncofetal lncRNA H19 was the first RNA identified as a riboregulator. Studying of this lncRNA revealed its implication in both normal development and diseases. In this review, we summarize the different mechanisms of action of H19 in human breast cancer. View Full-Text
Share & Cite This Article
Collette, J.; Le Bourhis, X.; Adriaenssens, E. Regulation of Human Breast Cancer by the Long Non-Coding RNA H19. Int. J. Mol. Sci. 2017, 18, 2319.
Collette J, Le Bourhis X, Adriaenssens E. Regulation of Human Breast Cancer by the Long Non-Coding RNA H19. International Journal of Molecular Sciences. 2017; 18(11):2319.Chicago/Turabian Style
Collette, Jordan; Le Bourhis, Xuefen; Adriaenssens, Eric. 2017. "Regulation of Human Breast Cancer by the Long Non-Coding RNA H19." Int. J. Mol. Sci. 18, no. 11: 2319.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.